46 related articles for article (PubMed ID: 28857144)
1. Abnormal activation of MAPKs pathways and inhibition of autophagy in a group of patients with Zellweger spectrum disorders and X-linked adrenoleukodystrophy.
Gragnaniello V; Gueraldi D; Puma A; Commone A; Cazzorla C; Loro C; Porcù E; Stornaiuolo M; Miglioranza P; Salviati L; Wanders RJA; Burlina A
Orphanet J Rare Dis; 2023 Nov; 18(1):358. PubMed ID: 37974207
[TBL] [Abstract][Full Text] [Related]
2. Lipidomic analysis of fibroblasts from Zellweger spectrum disorder patients identifies disease-specific phospholipid ratios.
Herzog K; Pras-Raves ML; Vervaart MA; Luyf AC; van Kampen AH; Wanders RJ; Waterham HR; Vaz FM
J Lipid Res; 2016 Aug; 57(8):1447-54. PubMed ID: 27284103
[TBL] [Abstract][Full Text] [Related]
3. It's Never Too Late for a Diagnosis.
Coelho M; Durães J; Freixo J; Tomás J; Macário C
Endocr Metab Immune Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37859411
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial disruption in peroxisome deficient cells is hepatocyte selective but is not mediated by common hepatic peroxisomal metabolites.
Shinde AB; Baboota RK; Denis S; Loizides-Mangold U; Peeters A; Espeel M; Malheiro AR; Riezman H; Vinckier S; Vaz FM; Brites P; Ferdinandusse S; Van Veldhoven PP; Baes M
Mitochondrion; 2018 Mar; 39():51-59. PubMed ID: 28866057
[TBL] [Abstract][Full Text] [Related]
5. Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder.
Berendse K; Koot BGP; Klouwer FCC; Engelen M; Roels F; Lacle MM; Nikkels PGJ; Verheij J; Poll-The BT
J Inherit Metab Dis; 2019 Sep; 42(5):955-965. PubMed ID: 31150129
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel heterozygous variant in the
Huang Y; Liu L; Fang F; Zhou H; Liu X
Transl Pediatr; 2024 Jan; 13(1):192-199. PubMed ID: 38323187
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.
Bose M; Yergeau C; D'Souza Y; Cuthbertson DD; Lopez MJ; Smolen AK; Braverman NE
Cells; 2022 Jun; 11(12):. PubMed ID: 35741019
[TBL] [Abstract][Full Text] [Related]
8. Zellweger spectrum disorder: A cross-sectional study of symptom prevalence using input from family caregivers.
Bose M; Cuthbertson DD; Fraser MA; Roullet JB; Gibson KM; Schules DR; Gawron KM; Gamble MB; Sacra KM; Lopez MJ; Rizzo WB
Mol Genet Metab Rep; 2020 Dec; 25():100694. PubMed ID: 33335840
[TBL] [Abstract][Full Text] [Related]
9. Structural Mapping of Missense Mutations in the Pex1/Pex6 Complex.
Schieferdecker A; Wendler P
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31374812
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype.
Enns GM; Ammous Z; Himes RW; Nogueira J; Palle S; Sullivan M; Ramirez C
Mol Genet Metab; 2021 Nov; 134(3):217-222. PubMed ID: 34625341
[TBL] [Abstract][Full Text] [Related]
11. Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.
Lipiński P; Stawiński P; Rydzanicz M; Wypchło M; Płoski R; Stradomska TJ; Jurkiewicz E; Ferdinandusse S; Wanders RJA; Vaz FM; Tylki-Szymańska A
J Appl Genet; 2020 Feb; 61(1):87-91. PubMed ID: 31628608
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.
Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM
J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031
[TBL] [Abstract][Full Text] [Related]
13. A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers.
Wangler MF; Hubert L; Donti TR; Ventura MJ; Miller MJ; Braverman N; Gawron K; Bose M; Moser AB; Jones RO; Rizzo WB; Sutton VR; Sun Q; Kennedy AD; Elsea SH
Genet Med; 2018 Oct; 20(10):1274-1283. PubMed ID: 29419819
[TBL] [Abstract][Full Text] [Related]
14. Zellweger Spectrum Disorder: Ophthalmic Findings from a New Natural History Study Cohort and Scoping Literature Review.
Yergeau C; Coussa RG; Antaki F; Argyriou C; Koenekoop RK; Braverman NE
Ophthalmology; 2023 Dec; 130(12):1313-1326. PubMed ID: 37541626
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a severity scoring system for Zellweger spectrum disorders.
Klouwer FCC; Meester-Delver A; Vaz FM; Waterham HR; Hennekam RCM; Poll-The BT
Clin Genet; 2018 Mar; 93(3):613-621. PubMed ID: 28857144
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
